Condition
Cervical Cancer by FIGO Stage 2018
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07461142Not ApplicableNot Yet RecruitingPrimary
Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers
NCT07368985Phase 2Not Yet RecruitingPrimary
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
NCT07305727Recruiting
A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
NCT05197881Not ApplicableRecruitingPrimary
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
Showing all 4 trials